Преглед аутора: "Jukić, Marin"
Приказ резултата 1-20 од 47
-
A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study
Pelgrim, Teuntje A. D.; Philipsen, Alexandra; Young, Allan H.; Juruena, Mario; Jimenez, Ester; Vieta, Eduard; Jukić, Marin; Van der Eycken, Erik; Heilbronner, Urs; Moldovan, Ramona; Kas, Martien J. H.; Jagesar, Raj R.; Nöthen, Markus M.; Hoffmann, Per; Shomron, Noam; Kilarski, Laura L; van Amelsvoort, Thérèse; Campforts, Bea; van Westrhenen, Roos (MDPI, 2024) -
Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder
Jukić, Marin; Carrillo-Roa, T; Bar, M; Becker, G; Jovanović, V.M; Zega, K; Binder, E.B; Brodski, C (Nature Publishing Group, 2015) -
Are adult neurogenesis and glucocorticoid signaling missing links between stress and depression? / Da li su adultna neurogeneza i glukokortikoidna signalizacija spona između stresa i depresije?
Jukić, Marin; Pešić, Vesna (Savez farmaceutskih udruženja Srbije, Beograd, 2016) -
Association between CYP2C19 genotype and body weight with escitalopram exposure – a cross sectional study
Jeremić, Aleksandra; Vuković, Petar; Vezmar, Milica; Pešić, Danilo; Drakulić, Jelena; Milosavljević, Filip; Miljević, Čedo; Marković, Bojan; Marić-Bojović, Nađa; Jukić, Marin (Elsevier, 2022) -
Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients
Miljević, Čedo D.; Nikolić-Kokić, Aleksandra; Blagojević, Duško; Milovanović, Maja; Munjiza, Ana; Jukić, Marin; Pešić, Vesna; Lecić-Tosevski, Dušica; Spasić, Mihajlo B. (Elsevier Ireland Ltd, Clare, 2018) -
BMP/SMAD pathway promotes neurogenesis of midbrain dopaminergic neurons in vivo and in human induced pluripotent and neural stem cells
Jovanović, V.M; Salti, A; Tilleman, H; Zega, K; Jukić, Marin; Zou, H; Friedel, R.H; Prakash, N; Blaess, S; Edenhofer, F; Brodski, C (Society for Neuroscience, 2018) -
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials
Milosavljević, Filip; Molden, Espen; Ingelman-Sundberg, Magnus; Jukić, Marin (Elsevier B.V., 2024) -
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
Joković, Danilo; Milosavljević, Filip; Stojanović, Zvezdana; Šupić, Gordana; Vojvodić, Danilo; Uzelac, Bojana; Jukić, Marin; Petković Ćurčin, Aleksandra (Elsevier Ireland Ltd, 2022) -
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients
Joković, Danilo; Milosavljević, Filip; Stojanović, Zvezdana; Šupić, Gordana; Vojvodić, Danilo; Jukić, Marin; Uzelac, Bojana; Petković-Ćurčić, Aleksandra (Elsevier, 2022) -
CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
Molden, Espen; Jukić, Marin (Frontiers Media S.A., 2021) -
Deciphering the spatio-temporal expression and stress regulation of Fam107B, the paralog of the resilience-promoting protein DRR1 in the mouse brain
Masana, M; Jukić, Marin; Kretzschmar, A; Wagner, K.V; Westerholz, S; Schmidt, M.V; Rein, T; Brodski, C; Müller, M.B (Elsevier Ltd, 2015) -
Dusp16 deficiency causes congenital obstructive hydrocephalus and brain overgrowth by expansion of the neural progenitor pool
Zega, K; Jovanović, V.M; Vitić, Z; Niedzielska, M; Knaapi, L; Jukić, Marin; Partanen, J; Friedel, R.H; Lang, R; Brodski, C (Frontiers Media S.A., 2017) -
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Jukić, Marin; Smith, Robert L.; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus (Elsevier Sci Ltd, Oxford, 2019) -
Effects of personalized dosing based on drug plasma level quantification on effectiveness and safety of escitalopram treatment
Vuković, Petar; Jeremić, Aleksandra; Vezmar, Milica; Pešić, Danilo; Drakulić, Jelena; Milosavljević, Filip; Miljević, Čedo; Marić-Bojović, Nađa; Jukić, Marin (Elsevier, 2022) -
Erratum: Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment (Molecular psychiatry (2016))
Jukić, Marin; Opel, N.; Ström, J.; Carrillo-Roa, T.; Miksys, S.; Novalen, M.; Renblom, A.; Sim, S.C.; Peñas-Lledó, E.M.; Couvert, Philippe; Llerena, A.; Baune, B.T.; de Quervain, D.J.; Papassotiropoulos, A.; Tyndale, R.F.; Binder, E.B.; Dannlowski, U.; Ingelman-Sundberg, Magnus (NLM (Medline), 2017) -
Functional characterization of CYP2D7 gene variants
Jukić, Marin; Lauschke, Volker M.; Saito, Takahiro; Hiratsuka, Masahiro; Ingelman-Sundberg, Magnus (Future Medicine Ltd, London, 2018) -
Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
Pridgeon, Chris; Bolhuis, Dian; Milosavljević, Filip; Manojlović, Marina; Végvári, Ákos; Gaetani, Massimiliano; Jukić, Marin; Ingelman-Sundberg, Magnus (MDPI, 2022) -
Humanized CYP2C19 transgenic mouse as an animal model of cerebellar ataxia
Milosavljević, Filip; Brusini, Irene; Atanasov, Andrea; Manojlović, Marina; Vučić, Marija; Oreščanin-Dušić, Zorana; Brkljačić, Jelena; Sitarica, Pavle; Miljević, Čedo; Nikolić-Kokić, Aleksandra; Blagojević, Duško; Wang, Chunliang; Damberg, Peter; Pešić, Vesna; Tyndale, Rachel; Ingelman-Sundberg, Magnus; Jukić, Marin (Elsevier, 2022) -
Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis
Milosavljević, Filip; Bukvić, Nikola; Pavlović, Zorana; Miljević, Čedo; Pešić, Vesna; Molden, Espen; Ingelman-Sundberg, Magnus; Leucht, Stefan; Jukić, Marin (Elsevier, 2020) -
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Jukić, Marin; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus (Amer Psychiatric Publishing, Inc, Washington, 2018)